Evidence map›Paper›PMID 29907088›Full record

ArticleBMC genomics2018

Development and application of an integrated allele-specific pipeline for methylomic and epigenomic analysis (MEA).

Julien Richard Albert, Tasuku Koike, Hamid Younesy, Richard Thompson, Aaron B Bogutz, Mohammad M Karimi, Matthew C Lorincz

Abstract readEvaluation Study
In one paragraph

Article in BMC genomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Modern epigenetics methods in biological research.Methods (San Diego, Calif.) · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Julien Richard AlbertDepartment of Medical Genetics, The University of British Columbia, Vancouver, BC, Canada.
Tasuku KoikeDepartment of BioScience, Tokyo University of Agriculture, Setagaya-ku, Tokyo, Japan.
Hamid YounesyGraphics Usability and Visualization Lab, School of Computing Science, Simon Fraser University, Burnaby, BC, Canada.
Richard ThompsonQatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
Aaron B BogutzDepartment of Medical Genetics, The University of British Columbia, Vancouver, BC, Canada.
Mohammad M KarimiMRC London Institute of Medical Sciences, Imperial College, London, UK. mahdi.karimi@lms.mrc.ac.uk.
Matthew C LorinczDepartment of Medical Genetics, The University of British Columbia, Vancouver, BC, Canada. mlorincz@mail.ubc.ca.ORCID http://orcid.org/0000-0003-0885-0467

Funding

Novel Therapies to Improve Functional Recovery After StrokeI01RX001141 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI TOMLINSON, STEPHEN · 2014 to 2022
–
Burden and Outcomes of Resistant Gram-negative Organisms in Veterans with SCI/DI21RX001583 · VA · EDWARD HINES JR VA HOSPITAL · PI EVANS, CHARLESNIKA T · 2015 to 2016
–
Canadian Institutes of Health Research MOP-133417Natural Sciences and Engineering Research Council of Canada RGPIN-2015-05228RRD VA I01 RX001141RRD VA I21 RX001583
6 · The paper itself

Abstract

backgroundAllele-specific transcriptional regulation, including of imprinted genes, is essential for normal mammalian development. While the regulatory regions controlling imprinted genes are associated with DNA methylation (DNAme) and specific histone modifications, the interplay between transcription and these epigenetic marks at allelic resolution is typically not investigated genome-wide due to a lack of bioinformatic packages that can process and integrate multiple epigenomic datasets with allelic resolution. In addition, existing ad-hoc software only consider SNVs for allele-specific read discovery. This limitation omits potentially informative INDELs, which constitute about one fifth of the number of SNVs in mice, and introduces a systematic reference bias in allele-specific analyses.

resultsHere, we describe MEA, an INDEL-aware Methylomic and Epigenomic Allele-specific analysis pipeline which enables user-friendly data exploration, visualization and interpretation of allelic imbalance. Applying MEA to mouse embryonic datasets yields robust allele-specific DNAme maps and low reference bias. We validate allele-specific DNAme at known differentially methylated regions and show that automated integration of such methylation data with RNA- and ChIP-seq datasets yields an intuitive, multidimensional view of allelic gene regulation. MEA uncovers numerous novel dynamically methylated loci, highlighting the sensitivity of our pipeline. Furthermore, processing and visualization of epigenomic datasets from human brain reveals the expected allele-specific enrichment of H3K27ac and DNAme at imprinted as well as novel monoallelically expressed genes, highlighting MEA's utility for integrating human datasets of distinct provenance for genome-wide analysis of allelic phenomena.

conclusionsOur novel pipeline for standardized allele-specific processing and visualization of disparate epigenomic and methylomic datasets enables rapid analysis and navigation with allelic resolution. MEA is freely available as a Docker container at https://github.com/julienrichardalbert/MEA .

Indexed as

AllelesDNA MethylationEpigenesis, GeneticSoftwareAnimalsChromatin ImmunoprecipitationCpG IslandsEpigenomicsGene Expression ProfilingGerm CellsHumansINDEL MutationMiceMice, Inbred C57BLMice, Inbred DBASequence Analysis, DNAAllele-specificAllelicChIPChIP-seqChromatin immunoprecipitationEpigenomicsImprintingMEARNA-seqWGBSWhole genome bisulphite-sequencing

Identifiers

PMID29907088
PMCPMC6003194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.